HAYWARD, Calif., Sept. 08, 2022 (GLOBE NEWSWIRE) — Since receiving FDA approval this year, Evo Visian® ICL (implantable contact lens) has quickly become one of the most effective solutions to correct myopia (myopia) and myopia with astigmatism. Patients who want to improve their vision permanently without having to be as dependent on glasses or contact lenses may be good candidates for this procedure. Cornea and refractive surgery specialist Mark Mandel, MD, is one of the first eye doctor in the Bay Area to offer this revolutionary new technology at Optima Ophthalmic Medical Associates.
“It is clear to me that EVO Visian® ICL provides superior results to previous versions of the implantable contact lenses“, said Mandel. “It is exciting to offer EVO to my patients who have difficulty seeing distant objects, and to be one of the first doctors in the Bay Area to perform this procedure.”
EVO Visian® ICL does not require any corneal tissue removal. It is an additive lens that is implanted in the eye. Due to its soft, flexible and biocompatible material, most patients experience clearer distance vision and improved night vision. The lenses provide UV protection and do not cause dry eye symptoms like some other refractive surgeries. Patients who have thin corneas or who are not otherwise good candidates for LASIK / PRK may find EVO a suitable alternative.
EVO Visian® ICL is an outpatient surgery that usually takes less than half an hour. Patients notice an improvement in vision within a day or two. Unlike any other refractive procedure, EVO ICL can be reversed in the future. However, most patients will retain their ICL for the rest of their lives.
Although the EVO ICL is new to the United States, more than one million people worldwide have received the EVO Visian® ICL. Proof of the technology’s effectiveness, over 99% of these patients say they would do it again.
Learn more about Mark Mandel, MD
Mark Mandel, MD, is a Bay Area corneal and refractive surgery specialist who has decades of experience improving patients’ sight with LASIK, the premium cataract surgery and phakic IOLs (intraocular lenses). He graduated from UCLA School of Medicine and Oxford University and completed his residency in ophthalmology at the prestigious California Pacific Medical Center in San Francisco and a corneal transplant fellowship at the University of Iowa. He is director of the corneal transplant service at California Pacific Medical Center. He is widely known as “The Doctor’s Doctor” as many other medical professionals trust him with surgeries on themselves, their families and their patients.
To learn more about EVO Visian® ICL and overcoming myopia, please schedule a consultation at Optima Ophthalmic Medical Associates via email [email protected] or by calling 877-210-2020, extension 3.
This content was published via the newswire.com press release distribution service.
Copyright 2022 GlobeNewswire, Inc.